Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity VRDN - Viridian Therapeutics, Inc.
490 M
LAST VALUE
55.16%
2 YEAR CAGR
49.28%
5 YEAR CAGR
63.14%
10 YEAR CAGR